<DOC>
	<DOCNO>NCT00960648</DOCNO>
	<brief_summary>The objective study evaluate safety long-term effectiveness coronary stenting everolimus-eluting stent ( EES ) determine clinical device procedural success commercial use EES real world . The investigator compare EES ( Xience/Promus , prospective arm ) sirolimus-eluting stent ( SES , Cypher , retrospective arm ) .</brief_summary>
	<brief_title>Registry Evaluate Efficacy Xience/Promus Versus Cypher Reducing Late Loss After Stenting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>The patient agree participate study sign informed consent form . Alternatively , legally authorize patient representative may agree patient 's participation study sign inform consent form . There exclusion criterion registry .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Everolimus</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Drug elute stent</keyword>
</DOC>